Mykhailo Mudryk, the Chelsea winger who has been sidelined since November 2024, saw his doping ban lifted after a successful appeal to the Court of Arbitration for Sport.
The Football Association had originally imposed a four‑year sanction after the Ukrainian international tested positive for meldonium in an out‑of‑competition test, a case that drew attention across the sport.
Following a review, the CAS partially upheld Mudryk’s challenge, reducing the penalty to a period that equates to the time he has already served, thereby allowing him to return to training without delay.
Mudryk, who signed for Chelsea in 2022 for a fee of £61 million from Shakhtar Donetsk and remains under contract until 2031, accepted the revised sanction and expressed gratitude for the resolution.
Chelsea’s sporting director welcomed the decision, stating that the club will support the player’s reintegration and help him regain full fitness ahead of the upcoming pre‑season tour.
The Legal Nuance Behind the Decision
The FA noted that recent amendments to the World Anti‑Doping Agency’s technical document on meldonium would have prevented the adverse finding had they been applied retroactively, a factor that influenced the appeal’s outcome.
The anti‑doping framework operated by the FA remains confidential, and the details of Mudryk’s case were only released after the appeal concluded, underscoring the discreet nature of such proceedings.
Had the original four‑year ban stood, Mudryk would have been barred from competitive football until December 2028, a timeline that now looks unlikely given the reduced sanction.